Journavx is the first and only approved non-opioid oral painkiller and the first new class of pain medicine approved in more ...
The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.
The list of recalled food products being elevated to Class I (the highest recall level) by the U.S. Food and Drug Administration (FDA) is continuing to grow. This time, the organization has updated ...
Vertex Pharmaceuticals won approval from the U.S. Food and Drug Administration for a non-opioid pain drug, clearing the way for the rollout of a product that has simultaneously sparked high hopes and ...
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
What will the industry face or achieve in 2025? These trends will be critical in medical device cybersecurity.
The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.
There is no evidence that a senior Food and Drug Administration (FDA) worker was arrested after samples of the H5N1 bird flu virus were found in his fridge. The narrative stems from a website whose ...
It was given to people who had acute surgical pain from either abdominoplasty, also known as a tummy tuck, or bunion surgery.
The U.S. Food and Drug Administration has approved Journavx (suzetrigine) 50 milligram oral tablets, marking the introduction of a first-in-class non-opioi ...
The recalled Braga Fresh Marketside Broccoli was washed, ready-to-eat, and sold in 12-ounce bags at Walmart stores in 20 states including Alaska, Arkansas, Arizona, California, Colorado, Idaho, ...
Analyst Andrew Fein of H.C. Wainwright maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), boosting the price target to ...